Building SaMD (Software as a Medical Device): Architecture, Compliance, and Challenges

Software as a Medical Device draws a hard regulatory line. Most engineering teams miss it until it costs them. Standalone clinical software performing a medical function (diagnostic decision support, treatment recommendation algorithms, patient monitoring tools) falls under FDA and MDR jurisdiction. Hardware involvement does not change that. That mandates a completely different development process. Validated architecture, documented risk management, & Cybersecurity controls are built in from day one. Treat SaMD development like standard software development, and you find the gap during FDA review, & the regulatory clock does not pause for architectural rework. 

What is Software as a Medical Device (SaMD)? 

SaMD meaning: medical device software executing specific medical purposes entirely independent of hardware. The IMDRF defined this category, and the FDA codified the framework directly within its Software as a Medical Device guidance. Whether deploying clinical decision support engines for diagnostic conclusions or utilizing patient monitoring medical device software to trigger care escalation, these systems fall squarely under this classification. All of it is subject to premarket review, post-market surveillance, and quality system regulation. The software-only classification does not reduce regulatory burden. It specifies it. 

Why SaMD Adoption is Growing Rapidly 

Digital therapeutics, AI medical software, and connected healthcare devices created an entire category of regulated software that operates outside physical device boundaries. FDA has cleared a growing roster of AI/ML-enabled medical devices through 510(k) and De Novo pathways. Remote monitoring. Clinical AI in EHR workflows. Prescription digital therapeutics are replacing or augmenting pharmacological treatment. Payers followed outcomes data into reimbursement coverage. Physicians accepted software-driven clinical inputs when evidence was held. The market grew because compliant SaMD delivered clinical results. Not because the compliance was easy. 

Core Architecture Components of SaMD Platforms 

 

Four structural layers govern every SaMD architecture. Healthcare cloud architecture sits under all of it. Clinical application, data integration, analytics, and AI, security. Modern medical software platforms build on that structure. Each layer performs independently and connects. 

Clinical Application Layer 

Interface and workflow logic for clinical inputs and decision outputs. Manages user interaction across device types and care settings. UX validation requirements under ISO 62366. Every interaction that influences a clinical decision is a documented risk item. Not a design preference. A regulatory artifact. Usability validation testing must produce objective evidence before submission. 

Data Integration Layer 

Connects the SaMD platform to EHRs, connected devices, labs, and imaging systems via FHIR APIs and HL7 standards. Every data source introduces integration risk that the validation process must account for. Data provenance, format consistency, and latency tolerances all require explicit specification. Undocumented data flows are audit liabilities. The integration architecture is a regulatory boundary condition, not a technical convenience. 

Analytics and AI Layer 

Where diagnostic algorithms, predictive models, and clinical scoring engines run. FDA treats AI/ML-enabled SaMD as a distinct regulatory pathway requiring algorithm training data documentation, performance benchmarks, and output confidence thresholds. Continuous learning models introduce additional change control obligations under FDA's predetermined change control plan framework. Build this layer with auditability as a core requirement. Algorithm performance that cannot be audited cannot be defended in a submission. 

Security and Compliance Layer 

Cybersecurity controls are premarket submission requirements. Not optional features. FDA medical device cybersecurity guidance mandates threat modeling, software bill of materials, and vulnerability management processes before submission. Encryption, access controls, audit logging, and incident response protocols are evaluated during review. A SaMD platform with an inadequate security architecture does not receive conditional clearance. It gets rejected. The rebuild cost is not a security investment. It is a preventable failure. 

Regulatory and Compliance Requirements for SaMD 

FDA medical software compliance starts with risk classification. Low-risk SaMD: 510(k) or exempt. Higher-risk: De Novo or PMA, with clinical validation data required. MDR compliance healthcare: CE marking under Regulation 2017/745. Post-market clinical follow-up standards that exceed legacy MDD. Two frameworks. Different submission mechanics. Same foundational requirement: quality system, validation-ready architecture, before touching submission paperwork. 

ISO 13485 and IEC 62304 documentation are mandatory under both regimes. SaMD validation starts at architecture. Design controls, ISO 14971 risk management, traceability matrices linking every requirement to test evidence: these are architecture-level decisions. Not paperwork added at the end. Teams that plan validation late find that their architecture does not support it. That is a rebuild and not a fix.

Read more